PICC Line Statistics in 2026: Complications, Thrombosis, and Best Use

Table of contents

• Fast facts
• PICC line statistics at a glance
• Complication rates and where they show up
• What the guideline data says about appropriate use
• Dwell time, lumen count, and infection risk
• Thrombosis, bloodstream infection, and mechanical removal data
• Practical reading of the numbers

Fast facts

PICC line statistics are most useful when they are read as a bundle: complication frequency, dwell time, patient setting, line complexity, and the reason the line was placed all change the risk profile.

Big number: a prospective cohort tracked 192 PICCs across 5,218 PICC-days and found an overall complication rate of 30.2% with a rate of 11.1 per 1,000 PICC-days (Grau et al., 2017).

That single figure is a useful anchor, but it is not the whole story. Across the supplied studies, complication rates ranged from low single digits in some subgroups to much higher levels in other settings, especially when line use, clinical context, and lumen count differed.

At a glance

• 30.2% overall complication rate in one prospective cohort of 192 PICCs (Grau et al., 2017)
• 14.4% overall complication rate in an oncology cohort of 522 PICCs (Parás-Bravo et al., 2020)
• 38% of 665 PICC scenarios rated appropriate in the Michigan MAGIC panel (MAGIC, 2015)
• 49.0% mean appropriate PICC use after intervention in a 38,592-PICC implementation study (Hammond et al., 2022)
• 2.31 infections per 1,000 catheter-days in one hospitalized adult study (Wright et al., 2014)
• 9.03 thromboses per 1,000 catheter-days in one pediatric thrombosis study (Myrup et al., 2016)

PICC line statistics at a glance

The dataset is strongest when it is grouped by outcome type. Some studies emphasize complications overall, while others break out infection, thrombosis, occlusion, and line removal reasons. That makes the numbers easier to compare and much more actionable.

Study or setting	Sample size	Main metric	Result
Prospective cohort (Grau et al., 2017)	192 PICCs	Overall complication rate	30.2%
Oncology cohort (Parás-Bravo et al., 2020)	522 PICCs	Overall complication rate	14.4%
MAGIC panel (MAGIC, 2015)	665 scenarios	Rated appropriate	38%
MAGIC implementation (Hammond et al., 2022)	38,592 PICCs	Appropriate PICC use after intervention	49.0%
Hospitalized adults (Wright et al., 2014)	966 PICCs	PICC-related bloodstream infection	5.2%
Pediatric thrombosis study (Myrup et al., 2016)	265 PICCs	PICC-related thrombosis	33.2%
Hematologic malignancy review (Dos Santos et al., 2024)	40 studies	PICC-related venous thrombosis prevalence	9%

These studies do not measure the same populations or use the same endpoints, so the table is best read as a directional map rather than a head-to-head ranking. Even so, the spread is informative: PICC outcomes vary sharply by context.

Complication rates and where they show up

The most straightforward complication data in the dataset comes from the prospective cohort and the oncology cohort. Those two studies alone show why a single “PICC complication rate” number can be misleading.

In the prospective cohort, overall complications reached 30.2% across 192 PICCs and 5,218 PICC-days (Grau et al., 2017). The same study reported a complication rate of 11.1 per 1,000 PICC-days, with a mean time to first complication of 16.1 days (Grau et al., 2017).

The component outcomes help explain that burden:

• Occlusion: 8.9% (Grau et al., 2017)
• Accidental withdrawal: 8.9% (Grau et al., 2017)
• Total infections: 6.3% (Grau et al., 2017)
• Local infections: 4.7% (Grau et al., 2017)
• Bloodstream infections: 1.6% (Grau et al., 2017)
• Venous thrombosis: 1.6% (Grau et al., 2017)
• Hematoma: 1.0% (Grau et al., 2017)

That mix matters because “complication” is not a single event. Some outcomes are mechanical, some are infectious, and some are vascular. If you only look at the final complication rate, you miss which failure modes are actually driving the burden.

The oncology cohort points in the same direction, though at a lower overall complication rate. In 522 PICCs, the study reported 75 complications and an overall complication rate of 14.4%, or 4.1 per 1,000 catheter-days (Parás-Bravo et al., 2020).

The leading events in that oncology cohort were:

• Local inflammation at the insertion site: 23 cases, or 4.4% (Parás-Bravo et al., 2020)
• Venous thrombosis: 15 cases, or 2.9% (Parás-Bravo et al., 2020)
• Bloodstream infection: 11 cases, or 2.1% (Parás-Bravo et al., 2020)
• Occlusion: 11 cases, or 2.1% (Parás-Bravo et al., 2020)

Why the spread matters

A 30.2% complication rate and a 14.4% complication rate might look like conflicting results, but they are really a reminder to look at setting, duration, and line purpose. Different patient mixes produce different outcomes.

What the guideline data says about appropriate use

Not all PICC use is equally justified, and the guideline data in the dataset is one of the clearest signals of that point.

The Michigan MAGIC panel reviewed 665 PICC scenarios and rated:

• 253 scenarios appropriate (38%) (MAGIC, 2015)
• 124 scenarios neutral or uncertain (19%) (MAGIC, 2015)
• 288 scenarios inappropriate (43%) (MAGIC, 2015)

That means the largest single category in the panel was inappropriate use. From a statistics perspective, that is a strong signal that utilization decisions matter before complications ever occur.

The panel’s duration guidance is also clear:

• PICC use for 5 or fewer days was rated inappropriate for peripherally compatible infusions (MAGIC, 2015)
• Midline catheters and ultrasound-guided peripheral IVs were preferred for 6 to 14 days (MAGIC, 2015)
• In critically ill patients, nontunneled central venous catheters were preferred when 14 or fewer days were expected (MAGIC, 2015)
• In cancer patients, PICCs were rated appropriate for irritant or vesicant infusion regardless of duration (MAGIC, 2015)

Those statements are not just clinical preferences. They explain why complication rates vary: the “wrong tool for the job” problem is built into the use pattern itself.

Appropriate use improved in implementation

The implementation study makes that point even more concrete. Across 38,592 PICCs in 52 Michigan hospitals, mean appropriate PICC use improved from 31.9% pre-intervention to 49.0% post-intervention (Hammond et al., 2022).

The same study found mean complication frequency fell from 14.7% to 10.7% after intervention (Hammond et al., 2022). It also reported lower odds of several adverse outcomes when use was appropriate:

• Complication odds: OR 0.29 (Hammond et al., 2022)
• Occlusion odds: OR 0.25 (Hammond et al., 2022)
• CLABSI odds: OR 0.61 (Hammond et al., 2022)
• VTE odds: OR 0.40 (Hammond et al., 2022)

The statistical message is straightforward: better alignment between indication and device use was associated with fewer downstream problems.

Dwell time, lumen count, and infection risk

Several numbers in the dataset point to dwell time and device complexity as major risk signals. These are important because they are often modifiable.

In ICU practice across 52 hospitals, vascular access nurses placed 6,268 PICCs, or 75.7%, while interventional radiology placed 933 ICU PICCs, or 11.3% (Chopra et al., 2018). The same study found:

• Median single-lumen use: 4.2% across hospitals, with an IQR of 2.0% to 8.0% (Chopra et al., 2018)
• 87% of hospitals reported a median ICU PICC dwell time of 14 days or less (Chopra et al., 2018)
• Median ICU PICC dwell time ranged from 3 to 38.5 days (Chopra et al., 2018)
• ICU PICC complications ranged from 0% to 40.2% across hospitals (Chopra et al., 2018)
• Only 13% of hospitals had a median ICU PICC duration of 15 days or longer (Chopra et al., 2018)

That spread is large enough to matter operationally. It suggests that hospital-level practice patterns can vary widely even before patient-level factors are considered.

Lumen count and bloodstream infection

The hospitalized adult study gives a strong example of how line complexity tracks with infection risk. In 966 PICCs inserted in 747 unique patients over 26,887 catheter-days, the study found that:

• Double-lumen PICCs had a hazard ratio of 4.08 for bloodstream infection (Wright et al., 2014)
• Triple-lumen PICCs had a hazard ratio of 8.52 for bloodstream infection (Wright et al., 2014)
• PICC-related bloodstream infection occurred in 25 patients, or 5.2% (Wright et al., 2014)
• The infection rate was 2.31 per 1,000 catheter-days (Wright et al., 2014)

The hierarchy here is hard to ignore: more lumens were associated with higher infection hazard. If a simpler line can meet the clinical need, the numbers suggest that simplification is not just tidy practice, it is risk management.

Thrombosis, bloodstream infection, and mechanical removal data

Thrombosis is one of the most important PICC outcomes in the dataset because it appears in multiple studies and with very different measurement approaches.

In the pediatric thrombosis study, 265 PICCs were inserted and 9,743 total follow-up days were recorded (Myrup et al., 2016). The study reported:

• PICC-related thrombosis: 88 insertions, or 33.2% (Myrup et al., 2016)
• Thrombosis incidence rate: 9.03 per 1,000 catheter-days (Myrup et al., 2016)
• Isolated superficial vein thrombosis: 66 insertions, or 24.9% (Myrup et al., 2016)
• Isolated DVT: 7 insertions, or 2.6% (Myrup et al., 2016)
• Superficial vein thrombosis with associated DVT: 15 insertions, or 5.7% (Myrup et al., 2016)
• Only 9.9% of superficial vein thrombosis cases were symptomatic (Myrup et al., 2016)
• Only 18.2% of DVT cases were symptomatic (Myrup et al., 2016)

The symptom data is especially useful. It shows that measured burden can be much larger than what is clinically obvious at the bedside.

A separate hematologic malignancy review included 40 studies and found PICC-related venous thrombosis prevalence of 9% overall, with adult prevalence at 9% and pediatric prevalence at 6% (Dos Santos et al., 2024). The review also noted that 25 studies, or 64%, focused on symptomatic thrombosis only (Dos Santos et al., 2024).

Mechanical removal and infection removal

Pediatric line removal data adds another angle on PICC burden. In one pediatric infection cohort:

• 26 catheters were accidentally dislodged, or 9.3% (Marschall et al., 2010)
• Mechanical removals totaled 38 catheters, or 13.6% (Marschall et al., 2010)
• Infectious removals also totaled 38 catheters, or 13.6% (Marschall et al., 2010)
• Phlebitis accounted for 13 removals, or 4.6% (Marschall et al., 2010)
• Exit-site infection accounted for 10 removals, or 3.5% (Marschall et al., 2010)
• PICC-associated bloodstream infection accounted for 12 removals, or 4.3% (Marschall et al., 2010)
• PICC-related bloodstream infection accounted for 4 removals, or 1.4% (Marschall et al., 2010)

This is another example of why removal reason matters. A catheter can leave service because of dislodgement, infection, thrombosis, or local tissue reaction, and each of those outcomes tells a different operational story.

Reading the numbers as a practical benchmark

If you are trying to interpret PICC line statistics for a site, ward, or quality project, the most useful approach is to separate the questions.

1. How often are PICCs used appropriately?

The MAGIC panel and the implementation study together suggest that appropriateness is not a soft concept. It is measurable, and it changed from 31.9% to 49.0% in one large implementation effort (Hammond et al., 2022), while the panel itself rated 43% of scenarios inappropriate (MAGIC, 2015).

2. What kind of complication is happening?

The dataset repeatedly separates:

• Occlusion
• Accidental withdrawal or dislodgement
• Local infection
• Bloodstream infection
• Venous thrombosis
• Hematoma

Those are not interchangeable events. A high occlusion rate points to a different fix than a high bloodstream infection rate.

3. Does line complexity fit the need?

The adult bloodstream infection study shows a steep hazard increase with more lumens: 4.08 for double-lumen and 8.52 for triple-lumen PICCs (Wright et al., 2014). That makes lumen count a key comparison point whenever a PICC is being considered.

4. Is dwell time pushing the line into a higher-risk window?

The cohort data show mean time to first complication of 16.1 days in one study (Grau et al., 2017), while the ICU survey found most hospitals reported a median dwell time of 14 days or less (Chopra et al., 2018). Those values suggest that time in situ is central to risk interpretation.

5. Are you comparing like with like?

The supplied studies span prospective cohorts, oncology patients, pediatric thrombosis cohorts, hospitalized adults, ICU practice surveys, and guideline panels. That breadth is useful, but it also means the correct statistical habit is comparison with caution.

The biggest lesson from these PICC line statistics is that “PICC risk” is not one number. It is a bundle of rates, settings, and practice choices, and the supplied studies show that bundle changing dramatically when appropriateness, dwell time, and line complexity change.